Neumonía por pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn

Daniela Fluxá; Jorge Segovia; Matías Florenzano; Jessica Salinas; Lilian Flores; Daniela Simian; Rodrigo P. Quera

doi:10.4067/S0716-10182017000500518

Neumonía por pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn

Translated title of the contribution: Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn´s disease

Daniela Fluxá
, Jorge Segovia
, Matías Florenzano
, Jessica Salinas
, Lilian Flores
, Daniela Simian
, Rodrigo P. Quera^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn´s disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.

Translated title of the contribution	Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn´s disease
Original language	Spanish
Pages (from-to)	518-519
Number of pages	2
Journal	Revista Chilena de Infectologia
Volume	34
Issue number	5
DOIs	https://doi.org/10.4067/S0716-10182017000500518
State	Published - Oct 2017
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2018, Sociedad Chilena de Infectologia. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.4067/S0716-10182017000500518

Cite this

@article{5efcf86eea37480db7375ef600e7d10f,

title = "Neumon{\'i}a por pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn",

abstract = "There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn´s disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.",

keywords = "Crohn´s colitis, Inflammatory bowel disease, Pneumocystis carinii, Pneumocystis jiroveci, Ulcerative colitis",

author = "Daniela Flux{\'a} and Jorge Segovia and Mat{\'i}as Florenzano and Jessica Salinas and Lilian Flores and Daniela Simian and Quera, \{Rodrigo P.\}",

year = "2017",

month = oct,

doi = "10.4067/S0716-10182017000500518",

language = "Spanish",

volume = "34",

pages = "518--519",

journal = "Revista Chilena de Infectologia",

issn = "0716-1018",

publisher = "Sociedad Chilena de Infectologia",

number = "5",

}

TY - JOUR

T1 - Neumonía por pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn

AU - Fluxá, Daniela

AU - Segovia, Jorge

AU - Florenzano, Matías

AU - Salinas, Jessica

AU - Flores, Lilian

AU - Simian, Daniela

AU - Quera, Rodrigo P.

PY - 2017/10

Y1 - 2017/10

N2 - There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn´s disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.

AB - There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn´s disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.

KW - Crohn´s colitis

KW - Inflammatory bowel disease

KW - Pneumocystis carinii

KW - Pneumocystis jiroveci

KW - Ulcerative colitis

UR - https://www.scopus.com/pages/publications/85042423210

U2 - 10.4067/S0716-10182017000500518

DO - 10.4067/S0716-10182017000500518

M3 - Article

C2 - 29488599

AN - SCOPUS:85042423210

SN - 0716-1018

VL - 34

SP - 518

EP - 519

JO - Revista Chilena de Infectologia

JF - Revista Chilena de Infectologia

IS - 5

ER -

Neumonía por pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this